e-Drug3D

1890

TRICLABENDAZOLE


INN
TRICLABENDAZOLE

(has an active metabolite)

cas 68786-66-3
CLASS

ANTIPARASITIC
ANTHELMINTIC
TREATMENT OF FASCIOLIASIS
TRICLABENDAZOLE AND ITS METABOLITES ARE ACTIVE AGAINST THE IMMATURE AND MATURE WORMS

ROUTE (list)

ORAL

ATC code

P02BX04

PK parameters

Tmax 3.5 HOUR
PPB 96.7 PERCENT
t1/2 8 HOUR

Target

-

PDB
7ERI (CRYSTAL STRUCTURE OF V30M-TTR IN COMPLEX WITH TRICLABENDAZOLE)

Ligand code = JA9 (link to the list of PDB complexes)

Download experimental 3D coordinates of JA9 with added hydrogens

DrugCentral

Unknown

Download SDF file 1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-

Formula:
C14H9Cl3N2OS

Calculated chemical properties:

MW 359.65
NB_atoms 21
XLogP 6.04
PSA 34.693
NB_HD 1
NB_HA 3
fsp3 0.07
Lipinski(0=no;1=yes) 0

FDA
NDA 208711 (label) INN (TRICLABENDAZOLE) EGATEN (NOVARTIS) APPROVAL= AP YEAR= 2019 NEWMOLECULARENTITY

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL